JJ

Jaywant Jagannath Bramhane

Director DIN 06438399
DIN 06438399 First appointment Mar 2013
Unlock full profile Investments Β· shareholding Β· contact details
Past companies 2 historical roles
Total affiliations 2 Since Mar 2013
Shareholding value β€’β€’β€’β€’ Premium profile

About Jaywant Jagannath Bramhane

Data last updated:

Jaywant Jagannath Bramhane was a Director at J. B. Shine Services Private Limited (from 2013) and Director at Jnsyn Pharmaceutical Private Limited (from 2013).

DIN 06438399
First Appointment 16 Mar 2013
Oldest Company Age 13 yrs

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
J. B. Shine Services Private Limited U93000MH2013PTC249492
Director23 Oct 20132013Strike Off
Jnsyn Pharmaceutical Private Limited U51101MH2013PTC241057
Director16 Mar 20132013Strike Off

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
J. B. Shine Services Private Limited
Jnsyn Pharmaceutical Private Limited
Premium access

Shareholding and investment profile for Jaywant Jagannath Bramhane

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Jaywant Jagannath Bramhane

Jaywant Jagannath Bramhane was first appointed on 16 Mar 2013 as Director at Jnsyn Pharmaceutical Private Limited.

Jaywant Jagannath Bramhane held 2 earlier board appointments: J. B. Shine Services Private Limited (Director, from 23 Oct 2013); Jnsyn Pharmaceutical Private Limited (Director, from 16 Mar 2013).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available